Doctors Propose Revisions to DSM Manual
What ends up (or doesn't) in the DSM manual, otherwise known as the bible of psychiatry, can have a major impact on patients, doctors and, of course, Big Pharma. So, it's no surprise that the debates and discussions around what will be included in the DSM's fifth edition are already involved and intense, some three years before the guidebook is due to be released.
What ends up (or doesn’t) in the DSM manual, otherwise known as the bible of psychiatry, can have a major impact on patients, doctors and, of course, Big Pharma. So, it’s no surprise that the debates and discussions around what will be included in the DSM’s fifth edition are already involved and intense, some three years before the guidebook is due to be released. –KA
Your support is crucial…The New York Times:
The eagerly awaited revisions — to be published, if adopted, in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, due in 2013 — would be the first in a decade.
For months they have been the subject of intense speculation and lobbying by advocacy groups, and some proposed changes have already been widely discussed — including folding the diagnosis of Asperger’s syndrome into a broader category, autism spectrum disorder.
But others, including a proposed alternative for bipolar disorder in many children, were unveiled on Tuesday. Experts said the recommendations, posted online at DSM5.org for public comment, could bring rapid change in several areas.
“Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who’s considered to be normal or not, for who’s considered disabled,” said Dr. Michael First, a professor of psychiatry at Columbia University who edited the fourth edition of the manual but is not involved in the fifth.
“And it has huge implications for stigma,” Dr. First continued, “because the more disorders you put in, the more people get labels, and the higher the risk that some get inappropriate treatment.”
With an uncertain future and a new administration casting doubt on press freedoms, the danger is clear: The truth is at risk.
Now is the time to give. Your tax-deductible support allows us to dig deeper, delivering fearless investigative reporting and analysis that exposes what’s really happening — without compromise.
Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and unearth untold stories.
Health & Wellness
The EPA is relying on industry-backed tests to relax regulations on acephate, which has been linked to neurodevelopmental disorders.
Global Voices
Despite promises of reform, Britain is institutionalizing growing numbers of young adults with autism and learning disabilities.
Dr. David Ayoub is once again challenging mainstream science, this time as an expert witness for accused child abusers.
Certain groups among the autistic tend to die 30 years earlier than their peers in the general population, and a charity is calling on Britain's National Health Service to find out why.
From midcentury institutions where children deemed feebleminded were committed to live in dark corners covered with their own excrement, to the millennial vaccine mania that corrupted autism research and set health policy back years, a new book paints the story of autism in sweeping, cinematic bursts.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.